ReNeuron Group PLC (FRA:RQE1)
€ 0.034 0 (0%) Market Cap: 2.28 Mil Enterprise Value: -3.31 Mil PE Ratio: 0 PB Ratio: 0.80 GF Score: 0/100

Full Year 2020 ReNeuron Group PLC Earnings Call Transcript

Jul 20, 2020 / 11:00AM GMT
Release Date Price: €1.47 (+2.73%)
Operator

Hello, and welcome to the ReNeuron Preliminary Results Conference Call. (Operator Instructions) And just to remind you, this conference call is being recorded. Today, I'm pleased to present Olav Hellebø, CEO. Please go ahead with your meeting.

Olav HellebÃ;ReNeuron Group plc;CEO;Director

¸,-&

Thank you very much. Good morning. Thanks, everyone, for joining this analyst meeting. I hope everyone is well, and we look forward to having one of these face-to-face again before too long.

Before we start digging into the presentation, if you do not have a copy of the slides, please go on to our website. There should be a link at the front page there or in the investor section where you can find the slides that will be easy to follow.

So let's start by turning to Slide #2 which is the disclaimer, so please note that. Then we'll jump to Slide #3. As you know already, ReNeuron is a leading cell therapy company. We're present in the U.K. and the U.S. And we have allogeneic retinal and neural stem cell technology

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot